Selective Serotonin Reuptake Inhibitors May Enhance Responses to Noxious Stimulation

[1]  J. Eisenach,et al.  Intrathecal Amitriptyline Acts as an N‐Methyl‐D‐Aspartate Receptor Antagonist in the Presence of Inflammatory Hyperalgesia in Rats , 1995, Anesthesiology.

[2]  S. Silberstein,et al.  Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine , 1994, Headache.

[3]  J. Levine,et al.  Interactions between fluoxetine and opiate analgesia for postoperative dental pain , 1994, Pain.

[4]  F. Mitchelson,et al.  Variation in the affinity of amitriptyline for muscarine receptor subtypes. , 1994, Pharmacology.

[5]  C. Gundlah,et al.  Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine , 1994, Neuroscience Letters.

[6]  R. Dirksen,et al.  Site- and test-dependent antinociceptive efficacy of amitriptyline in rats , 1994, Pharmacology Biochemistry and Behavior.

[7]  F. Wolfe,et al.  A double-blind placebo controlled trial of fluoxetine in fibromyalgia. , 1994, Scandinavian journal of rheumatology.

[8]  P. Dayer,et al.  Central analgesic effects of desipramine, fluvoxamine, and moclobemide after single oral dosing: A study in healthy volunteers , 1993, Clinical pharmacology and therapeutics.

[9]  R. Dirksen,et al.  The intrathecal effectiveness of four short acting local anesthetics in rats: a single concentration-response relationship , 1993, Regional Anesthesia & Pain Medicine.

[10]  Roberto Invernizzi,et al.  Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex , 1992, Brain Research.

[11]  R Dubner,et al.  Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. , 1992, The New England journal of medicine.

[12]  R. Dirksen,et al.  The dose‐response and time‐effect relationships of intrathecal bupivacaine in rats. The influence of epinephrine and pH , 1992, Acta anaesthesiologica Scandinavica.

[13]  C. Beasley,et al.  Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. , 1991, BMJ.

[14]  R. Dirksen.  Analgesiology: A New Approach to Pain , 1991 .

[15]  K. Brøsen,et al.  The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms , 1990, Pain.

[16]  Ben Tura,et al.  The analgesic effect of tricyclic antidepressants , 1990, Brain Research.

[17]  R. M. Bowker,et al.  Quantitative re-evaluation of descending serotonergic and non-serotonergic projections from the medulla of the rodent: evidence for extensive co-existence of serotonin and peptides in the same spinally projecting neurons, but not from the nucleus raphe magnus , 1990, Brain Research.

[18]  R. Dirksen,et al.  Intrathecal naloxone but not pentazocine reverses the effect of intravenous morphine in rats , 1990 .

[19]  David A. McCormick,et al.  Noradrenaline and serotonin selectively modulate thalamic burst firing by enhancing a hyperpolarization-activated cation current , 1989, Nature.

[20]  R. Dirksen,et al.  Dipropylacetate-induced shaking behaviour in the rat: a role of spinal α2-adrenoceptors , 1988 .

[21]  P. Eide,et al.  Apparent hyperalgesia after lesions of the descending serotonergic pathways is due to increased tail skin temperature , 1988, Pain.

[22]  M. Wessendorf,et al.  The coexistence of serotonin- and substance P-like immunoreactivity in the spinal cord of the rat as shown by immunofluorescent double labeling , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  P. Conlon,et al.  Tricyclic antidepressants in the treatment of cancer pain: a review. , 1987, Pharmacopsychiatry.

[24]  G. Wilcox,et al.  Analgesic properties of intrathecally administered heterocyclic antidepressants , 1987, Pain.

[25]  M. L. de Ceballos,et al.  Hypoalgesia induced by antidepressants in mice: a case for opioids and serotonin. , 1986, European journal of pharmacology.

[26]  M. Randić,et al.  Altered responsiveness to substance P and 5-hydroxytryptamine in cat dorsal horn neurons after 5-HT depletion with p-chlorophenylalanine , 1986, Brain Research.

[27]  J. Turner,et al.  Chronic pain and depression: does the evidence support a relationship? , 1985, Psychological bulletin.

[28]  H. Hall,et al.  Acute effects of atypical antidepressants on various receptors in the rat brain. , 2009, Acta pharmacologica et toxicologica.

[29]  M. Vogt,et al.  Involvement of 5-hydroxytryptamine-containing neurons in antinociception produced by injection of morphine into nucleus raphe magnus or onto spinal cord , 1984, Brain Research.

[30]  J. Millar,et al.  Receptive fields and responses to ionophoretically applied nonradrenaline and 5-hydroxytryptamine of units recorded in laminae I–III of cat dorsal horn , 1983, Brain Research.

[31]  H. Takagi,et al.  Separate involvement of the spinal noradrenergic and serotonergic systems in morphine analgesia: the differences in mechanical and thermal algesic tests , 1983, Brain Research.

[32]  O. Berge.  Effects of 5-HT receptor agonists and antagonists on a reflex response to radiant heat in normal and spinally transected rats , 1982, PAIN.

[33]  H. Echizen,et al.  Long-term infusion of L-5-hydroxytryptophan increases brain serotonin turnover and decreases blood pressure in normotensive rats. , 1982, The Journal of pharmacology and experimental therapeutics.

[34]  M. Krstić,et al.  Comparison of the cardiovascular responses to intracerebroventricular administration of tryptamine, 5-hydroxytryptamine, tryptophan and 5-hydroxytryptophan in rats. , 1981, Archives internationales de physiologie et de biochimie.

[35]  A. Duggan,et al.  Prolonged depression of spinal transmission of nociceptive information by 5-HT administered in the substantia gelatinosa: antagonism by methysergide , 1980, Brain Research.

[36]  Anthony H. Dickenson,et al.  Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat , 1979, PAIN.

[37]  M. F. Sugrue.  ON THE ROLE OF 5‐HYDROXYTRYPTAMINE IN DRUG‐INDUCED ANTINOCICEPTION , 1979, British journal of pharmacology.

[38]  W. Willis,et al.  Two populations of spinothalamic tract neurons with opposite responses to 5-hydroxytryptamine , 1979, Brain Research.

[39]  T. Yaksh,et al.  Spinal serotonin terminal system mediates antinociception. , 1979, The Journal of pharmacology and experimental therapeutics.

[40]  H. Takagi,et al.  Antagonism by phenoxybenzamine of the analgesic effect of morphine injected into the nucleus reticularis gigantocellularis of the rat , 1979, Neuropharmacology.

[41]  T. Yaksh.  Direct evidence that spinal serotonin and noradrenaline terminals mediate the spinal antinociceptive effects of morphine in the periaqueductal gray , 1979, Brain Research.

[42]  R. Ryall,et al.  The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurones in the cat , 1978, Brain Research.

[43]  P. Greengard,et al.  Brain histamine receptors as targets for antidepressant drugs , 1978, Nature.

[44]  S. Ross,et al.  Tricyclic antidepressant agents. I. Comparison of the inhibition of the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices and crude synaptosome preparations of the midbrain-hypothalamus region of the rat brain. , 2009, Acta pharmacologica et toxicologica.

[45]  D. Wong,et al.  A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. , 1974, Life sciences.

[46]  F. Weight,et al.  Responses of spinal cord interneurons to acetylcholine, norepinephrine and serotonin administered by microelectrophoresis. , 1966, The Journal of pharmacology and experimental therapeutics.

[47]  J. Glowinski,et al.  Inhibition of Uptake of Tritiated-noradrenaline in the Intact Rat Brain by Imipramine and Structurally Related Compounds , 1964, Nature.